These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33615945)

  • 1. New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies.
    Morley KC; Perry CJ; Watt J; Hurzeler T; Leggio L; Lawrence AJ; Haber P
    Expert Opin Pharmacother; 2021 Jul; 22(10):1291-1303. PubMed ID: 33615945
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacotherapy of alcoholism - an update on approved and off-label medications.
    Soyka M; Müller CA
    Expert Opin Pharmacother; 2017 Aug; 18(12):1187-1199. PubMed ID: 28658981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selecting an appropriate alcohol pharmacotherapy: review of recent findings.
    Castrén S; Mäkelä N; Alho H
    Curr Opin Psychiatry; 2019 Jul; 32(4):266-274. PubMed ID: 30973369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.
    Burnette EM; Nieto SJ; Grodin EN; Meredith LR; Hurley B; Miotto K; Gillis AJ; Ray LA
    Drugs; 2022 Feb; 82(3):251-274. PubMed ID: 35133639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol addiction - the safety of available approved treatment options.
    Antonelli M; Ferrulli A; Sestito L; Vassallo GA; Tarli C; Mosoni C; Rando MM; Mirijello A; Gasbarrini A; Addolorato G
    Expert Opin Drug Saf; 2018 Feb; 17(2):169-177. PubMed ID: 29120249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on the pharmacological management of alcohol use disorder: Are the approved medications effective?
    Antonelli M; Sestito L; Tarli C; Addolorato G
    Eur J Intern Med; 2022 Sep; 103():13-22. PubMed ID: 35597734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies.
    Leggio L; Falk DE; Ryan ML; Fertig J; Litten RZ
    Handb Exp Pharmacol; 2020; 258():443-462. PubMed ID: 31628604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
    Litten RZ; Wilford BB; Falk DE; Ryan ML; Fertig JB
    Subst Abus; 2016; 37(2):286-98. PubMed ID: 26928397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing drugs for treatment of alcohol use disorder.
    Aubin HJ
    Int Rev Neurobiol; 2024; 175():153-185. PubMed ID: 38555115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.
    Palpacuer C; Duprez R; Huneau A; Locher C; Boussageon R; Laviolle B; Naudet F
    Addiction; 2018 Feb; 113(2):220-237. PubMed ID: 28940866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel human laboratory model for screening medications for alcohol use disorder.
    Ho D; Towns B; Grodin EN; Ray LA
    Trials; 2020 Nov; 21(1):947. PubMed ID: 33225963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder.
    Köhne S; Hillemacher T; Glahn A; Bach P
    Expert Opin Emerg Drugs; 2024 Sep; 29(3):219-232. PubMed ID: 38606899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacotherapeutic management of comorbid bipolar disorder and alcohol use disorder.
    Grunze H; Soyka M
    Expert Opin Pharmacother; 2022 Jul; 23(10):1181-1193. PubMed ID: 35640575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Developments in Pharmacotherapy of Alcoholism.
    Soyka M; Lieb M
    Pharmacopsychiatry; 2015 Jul; 48(4-5):123-35. PubMed ID: 25761458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medications for treating alcohol use disorder: A narrative review.
    Kranzler HR; Hartwell EE
    Alcohol Clin Exp Res (Hoboken); 2023 Jul; 47(7):1224-1237. PubMed ID: 37526592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol Use Disorder: The Role of Medication in Recovery.
    Mason BJ; Heyser CJ
    Alcohol Res; 2021; 41(1):07. PubMed ID: 34113531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in Pharmacotherapy Development: Human Clinical Studies.
    Litten RZ; Falk DE; Ryan ML; Fertig J; Leggio L
    Handb Exp Pharmacol; 2018; 248():579-613. PubMed ID: 29294197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current pharmacological treatment approaches for alcohol dependence.
    Müller CA; Geisel O; Banas R; Heinz A
    Expert Opin Pharmacother; 2014 Mar; 15(4):471-81. PubMed ID: 24456374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of nalmefene for the treatment of alcohol use disorder: an update.
    López-Pelayo H; Zuluaga P; Caballeria E; Van den Brink W; Mann K; Gual A
    Expert Opin Drug Saf; 2020 Jan; 19(1):9-17. PubMed ID: 31868031
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenetics of alcohol use disorder treatments: an update.
    Hartwell EE; Kranzler HR
    Expert Opin Drug Metab Toxicol; 2019 Jul; 15(7):553-564. PubMed ID: 31162983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.